• Why pharma branded work didn’t make the Cannes cut

  • Jul 3 2024
  • Duración: 44 m
  • Podcast

Why pharma branded work didn’t make the Cannes cut Por arte de portada

Why pharma branded work didn’t make the Cannes cut

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Collette Douaihy, 2024 Cannes Lions Pharma jury president, CCO at Dentsu Health and 2024 MM+M Health Influencer, explains the dearth of award-caliber, regulated pharma work from this year’s festival in the south of France.

    Plus, Marc Iskowitz, Lecia Bushak and Jack O’Brien review recent Supreme Court decisions impacting healthcare. These include the court’s biggest abortion-related rulings since overturning Roe v. Wade two years ago to its rejection of the Purdue Pharma nationwide opioid settlement to its rollback of the 40-year-old Chevron defense.

    Check us out at: mmm-online.com

    Follow us:

    YouTube: @MMM-online

    TikTok: @MMMnews

    Instagram: @MMMnewsonline

    Twitter/X: @MMMnews

    LinkedIn: MM+M

    To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
    Más Menos
activate_primeday_promo_in_buybox_DT
Economía
Más Menos

Lo que los oyentes dicen sobre Why pharma branded work didn’t make the Cannes cut

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles